Overview
The Black Book of Psychotropic Dosing and Monitoring stands as the definitive clinical reference guide for healthcare professionals navigating the complex landscape of modern psychopharmacology. Authored by leading experts Dr. Charles DeBattista and Dr. Alan F. Schatzberg from Stanford University, this comprehensive resource provides evidence-based dosing guidelines, monitoring protocols, and safety information for the complete spectrum of psychotropic medications. Updated regularly to reflect the latest FDA approvals and clinical developments, The Black Book serves as an indispensable tool for psychiatrists, primary care physicians, and mental health professionals seeking authoritative guidance on psychotropic prescribing and patient management.
Clinical Content & Evidence
The Black Book encompasses cutting-edge developments in psychopharmacology, featuring comprehensive coverage of novel antidepressants including rapidly-acting agents like esketamine (Spravato) and brexanolone (Zulresso), innovative antipsychotics such as cariprazine and lumateperone, and breakthrough psychedelic-assisted therapy protocols. The guide provides detailed dosing ranges, pharmacokinetic parameters, drug interaction profiles, and monitoring requirements for over 100 psychotropic medications across all major therapeutic categories.
Grounded in rigorous scientific methodology with over 100 peer-reviewed references and FDA-approved prescribing information, The Black Book delivers unparalleled clinical utility through systematic organization of complex psychopharmacological information into immediately accessible, practical guidance. Unlike general reference texts, this specialized resource focuses exclusively on the dosing and monitoring challenges that define successful psychotropic prescribing, eliminating guesswork in clinical decision-making while enhancing patient safety through comprehensive drug interaction tables and evidence-based monitoring protocols.
Target Audience
- Psychiatrists and Psychopharmacologists – Specialists requiring comprehensive dosing and monitoring guidance for complex patient populations
- Primary Care Physicians – Healthcare providers managing psychiatric conditions in general practice settings
- Clinical Pharmacists – Pharmacy professionals involved in psychotropic medication management and consultation
- Psychiatric Residents and Fellows – Medical trainees developing expertise in psychopharmacological practice
- Mental Health Institutions – Hospitals, clinics, and healthcare systems requiring standardized prescribing protocols
Access This Reference Guide
Choose your preferred access method for the Black Book of Psychotropic Dosing and Monitoring
